Zinc trifluoromethanesulfonate Cas:54010-75-2

We are Zinc trifluoromethanesulfonate CAS:54010-75-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Zinc trifluoromethanesulfonate

Trifluoromethanesulfonic acid zinc salt
Zinc(II) Trifluoromethanesulfonate
Zinc(II) Triflate
Trifluoromethanesulfonic Acid Zinc(II) Salt
Zinc triflate
Molecular Formula: C2F6O6S2Zn
Molecular weight:363.51800

Appearance and properties: white to light gray powder
Density: 4.43
Boiling point: 162ºC at 760 mmHg
Melting point: ≥300 °C(lit.)
Storage conditions: Refrigerator

Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.

Market News: A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge.10-((4-((Z)-(3,6-dioxo-5-((Z)-4-(thiophene-2-carboxamido)benzylidene)piperazin-2-ylidene)methyl)phenyl)amino)-10-oxodecanoic acid manufacturer.CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 4-(4-amino-phenyl)-[1,4]-diazepan-1-carboxamidine supplier In 2021, the combo has raked in $818 million in the first half of the year alone for Novartis, a number that is already up 11% from last year. Comparatively, Roche reported $218 million in sales of Zelboraf in 2016, and revenue was not reported in its most recent mid-year update. 2α-(1-Hydroxy-1-methyl)-ethyl-cholestanon-(3) producer

Related Products
Product Name
fluoromethanol,4-methylbenzenesulfonic acid Cas:114435-86-8 View Details
4-Pyridazinecarboxylic acid View Details
Isovanillin Cas:621-59-0 View Details
8-Hydroxyquinoline aluminum salt Cas:2085-33-8 manufacturer photoinitiator 1190 Cas:68156-13-8 manufacturer Ethylmethylamine Cas:624-78-2 manufacturer Oxetan-3-yl 4-methylbenzenesulfonate Cas:26272-83-3 manufacturer METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL Cas:12108-13-3 manufacturer